{"id":5364,"date":"2025-08-22T16:39:30","date_gmt":"2025-08-22T08:39:30","guid":{"rendered":"https:\/\/uni-pharma.com.tw\/article_column\/%e3%80%8c%e4%b8%8d%e8%83%bd%e7%ad%89%e7%9a%84%e7%97%85%e3%80%8dnmosd%e7%97%85%e5%8f%8b%e9%bd%8a%e8%81%9a-%e9%86%ab%e7%95%8c%e7%99%bc%e8%81%b2%e7%b1%b2%e6%94%be%e5%af%ac%e8%97%a5%e7%89%a9%e7%b5%a6\/"},"modified":"2025-09-08T17:14:33","modified_gmt":"2025-09-08T09:14:33","slug":"nmosd_udnnesw","status":"publish","type":"article_column","link":"https:\/\/uni-pharma.com.tw\/en\/article_column\/nmosd_udnnesw\/","title":{"rendered":"\u201cA Disease That Can\u2019t Wait\u201d \u2014 NMOSD Patients Rally and Medical Community Calls for Broader Drug Coverage"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>Source:<\/strong> United Daily News via Health Business Division \u00b7 2025-08-22<\/p>\n\n\n\n<h2 class=\"wp-block-heading has-medium-font-size\"><strong>Headline Summary:<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) and their supporters gathered at the \u201cSeize the Treatment Window, Reclaim Your Vision!\u201d support event organized by the Taiwan Neuro-Immunology &amp; Movement Education Association. The event fostered supportive dialogue and emphasized the urgency of timely treatment.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\"><strong>Event Highlights and Key Messages<\/strong><\/h4>\n\n\n\n<h4 class=\"wp-block-heading has-medium-font-size\"><strong>Early Diagnosis &amp; Treatment Are Vital:<\/strong><\/h4>\n\n\n\n<p class=\"wp-block-paragraph\">Dr. Nai-Wen Tsai from Chang Gung Memorial Hospital Kaohsiung underscored the importance of timely diagnosis and treatment in controlling NMOSD. Psychiatrist Dr. Hung Chi-Fa addressed the emotional toll NMOSD patients often face\u2014anxiety, uncertainty, and self-doubt\u2014and stressed the need for psychological support to enhance overall well-being.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\"><strong>Healing through Horticultural Therapy:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Participants experienced a calming horticultural session led by therapists Chia-Hua Ho and Jin-Feng Hsu. One attendee shared: \u201cLiving with a chronic illness is arduous. These gentle, healing activities reminded us we\u2019re not alone.\u201d The organizers pledged to continue supporting patient advocacy and education.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\"><strong>NMOSD: A Rapidly Disabling Autoimmune Disease:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">NMOSD is a relapsing, rare autoimmune disorder often affecting women, leading to recurrent inflammation in the optic nerve and spinal cord. A 2024 study cited by <em>Clinical &amp; Translational Neurology<\/em> reports NMOSD patients face a threefold higher mortality rate, with a third dying due to disability caused by relapse. Early medical intervention is critical for long-term disease control.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\"><strong>Improved Prognosis, but Access Remains Limited:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Advances in diagnosis, such as autoantibody testing, have enabled better discrimination between NMOSD and multiple sclerosis (MS). Monoclonal antibody treatments have dramatically lowered five-year mortality rates from 30% to 2%. Still, particularly in severe cases, timely access to these effective therapies remains essential to prevent disability and preserve daily function.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\"><strong>Drug Coverage Policy Needs Reform:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Currently, National Health Insurance (NHI) requires patients experience two relapses within a year plus functional decline to qualify for coverage. Dr. Tsai criticized this threshold, noting that some patients who relapse just outside this window\u2014despite severe disease\u2014are excluded. Of the 92 patients covered by December 2024, fewer than 20% of those in dire need received access. Looser criteria, such as allowing eligibility when two relapses occur within two years, could better align with clinical realities.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\"><strong>The Medical Community and Lawmakers Lend Support:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">In a press conference organized by NMOSD patient groups, several legislators\u2014including Wang Yu-Min, Chen Ching-Hui, Huang Shan-Shan, and Su Chiao-Hui\u2014called for reform. They emphasized that no patient deserves to worsen while waiting for treatment. A recent Legislative Yuan health committee session echoed this urgency, urging Bolstered insurance access to improve care equity.<\/p>\n\n\n\n<h3 class=\"wp-block-heading has-medium-font-size\"><strong>Hidden Psychological Impact on Patients:<\/strong><\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Over 80% of NMOSD patients are women in their prime caregiving years. The unpredictable nature of relapses often triggers feelings of guilt, fear, and emotional conflict. Dr. Hung highlighted that around half of these patients also experience depression, anxiety, or sleep disturbances\u2014making long-term mental health support imperative.<\/p>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/pgw.udn.com.tw\/gw\/photo.php?u=https:\/\/uc.udn.com.tw\/photo\/2025\/04\/02\/0\/31767226.jpg&amp;x=0&amp;y=0&amp;sw=0&amp;sh=0&amp;exp=3600\" alt=\"\u6d3b\u52d5\u5c3e\u8072\u5b89\u6392\u5712\u85dd\u8f14\u7642\u9ad4\u9a57\uff0c\u8c61\u5fb5\u75c5\u53cb\u8207\u5bb6\u5c6c\u4e00\u8d77\u300c\u7a2e\u4e0b\u5e0c\u671b\u300d\uff0c\u611f\u53d7\u81ea\u7136\u7642\u7652\u529b\u91cf\u3002\u5716\/\u53f0\u7063\u795e\u7d93\u5065\u5eb7\u66a8\u904b\u52d5\u6559\u80b2\u5354\u6703\"\/><\/figure>\n\n\n\n<figure class=\"wp-block-image\"><img decoding=\"async\" src=\"https:\/\/pgw.udn.com.tw\/gw\/photo.php?u=https:\/\/uc.udn.com.tw\/photo\/2025\/04\/02\/0\/31767237.jpg&amp;x=0&amp;y=0&amp;sw=0&amp;sh=0&amp;exp=3600\" alt=\"<br&gt;\u53f0\u7063\u795e\u7d93\u5065\u5eb7\u66a8\u904b\u52d5\u6559\u80b2\u5354\u6703\u8209\u8fa6\u6cdb\u8996\u795e\u7d93\u810a\u9ad3\u708e\uff08NMOSD\uff09\u75c5\u53cb\u652f\u6301\u6d3b\u52d5\uff0c\u73fe\u5834\u6c23\u6c1b\u6eab\u99a8\u71b1\u7d61\u3002\u5716\/\u53f0\u7063\u795e\u7d93\u5065\u5eb7\u66a8\u904b\u52d5\u6559\u80b2\u5354\u6703\"\/><\/figure>\n\n\n\n<h2 class=\"wp-block-heading has-medium-font-size\"><strong>Conclusion: Bridging the Gap Between Clinical Advancements and Health Equity<\/strong><\/h2>\n\n\n\n<p class=\"wp-block-paragraph\">Medical breakthroughs have transformed NMOSD outcomes. Yet the current NHI coverage structure fails to fully match these advances, leaving many patients with biological and emotional burdens. The path forward requires policy reform that puts patient needs first\u2014ensuring timely access to effective therapies and holistic care. Only then can NMOSD patients be assured the life and support they urgently need.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Source: United Daily News via Health Business Division \u00b7 2025-08-22 Headline Summary: Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) and their supporters gathered at the \u201cSeize the Treatment Window, Reclaim Your Vision!\u201d support event organized by the Taiwan Neuro-Immunology &amp; Movement Education Association. The event fostered supportive dialogue and emphasized the urgency of timely treatment. [&hellip;]<\/p>\n","protected":false},"author":8,"featured_media":5341,"parent":0,"template":"","tags":[231,239,240,219,220],"article_column_cat":[215,230],"class_list":["post-5364","article_column","type-article_column","status-publish","has-post-thumbnail","hentry","tag-autoimmune-antibody-test","tag-nmosd-en","tag-mogad-en","tag-medical-testing","tag-mayo-clinic-en","article_column_cat-health-information","article_column_cat-autoimmune-antibodies"],"blocksy_meta":[],"acf":[],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/article_column\/5364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/article_column"}],"about":[{"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/types\/article_column"}],"author":[{"embeddable":true,"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/users\/8"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/media\/5341"}],"wp:attachment":[{"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/media?parent=5364"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/tags?post=5364"},{"taxonomy":"article_column_cat","embeddable":true,"href":"https:\/\/uni-pharma.com.tw\/en\/wp-json\/wp\/v2\/article_column_cat?post=5364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}